DPP4 and infection: Specifically, while knockdown of BSG/CD147 or treatment with DPP4 inhibitor (vildagliptin) significantly reduces SARS-CoV-2 infection, conversely overexpressing BSG/CD147 or DPP4 increases infection in vitro.